Fat-globule size in a propofol emulsion containing sodium metabisulfite

American Journal of Health-System Pharmacy

Volumn 61, Issue 12, 2004, Pages 1276-1280

  Driscoll, David F ^a,b   Dunbar, Jana G ^c   Marmarou, Anthony ^d  

^a Sterile Product Compounding Unit   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MCV   (United States)

Author keywords

Anesthetics; Emulsions; Injections; Particle size distribution; Preservatives; Propofol; Sodium metabisulfite; Stability; Storage

Indexed keywords

EDETIC ACID; LIPID EMULSION; LIPOSOME; PROPOFOL; SODIUM METABISULFITE;

ARTICLE; CONTROLLED STUDY; DRUG STORAGE; EXPIRATION DATE; PH; PRIORITY JOURNAL;

EID: 8344259170     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.12.1276     Document Type: Article

References (27)

1. Pelham LD. Rational use of intravenous fat emulsions. Am J Hosp Pharm. 1982; 38:198-208.
2. Driscoll DF. Intravenous lipid emulsions 2001. Nutr Clin Pract. 2001; 16: 215-8.
3. Davis SS, Hadgraft J, Palin KJ. Medical and pharmaceutical applications of emulsions. In: Beecher P, ed. Encyclopedia of emulsion technology. Vol. 2. Applications. New York: Dekker; 1985:159-238.
4. United States Pharmacopeia. Injectable lipid emulsion. Proposed monograph, inprocess revision. Pharm Forum. 2003; 29: 421-3.
5. Washington C. The stability of intravenous fat emulsions in total parenteral nutrition mixtures. Int J Pharm. 1990; 66:1-21.
6. Guyton AC. The microcirculation and the lymphatic system: capillary fluid exchange, interstitial fluid, and lymph flow. In: Guyton AC, ed. Textbook of medical physiology. 8th ed. Philadelphia: Saunders; 1991:170-84.
7. United States Pharmacopeia. Globule size distribution in intravenous emulsions. Proposed 〈chapter 729〉, in-process revision. Pharm Forum. 1998; 24:6988-94.
8. Driscoll DF, Ling PR, Quist WC et al. Tissue damage from unstable fat globules in the reticuloendothelial system (RES) organs of guinea pigs following a 24-hour all-in-one infusion. Clin Nutr. 2002; 21 (suppl 1):63,P-50.
9. Driscoll DF, Ling PR, Quist WC et al. Hepatic indicators of inflammation following the infusion of pharmaceutically unstable all-in-one mixtures in rats. Clin Nutr. 2003; 22(suppl 1):S16-7,O-59.
10. Driscoll DF, Dunbar J, Marmarou A. Toxicological significance of parenteral drug emulsions and large-diameter tails: a comparison of propofol formulations. Paper presented at American Society of Anesthesiologists Annual Meeting. San Francisco, CA; 2003 Oct 13.
11. Hulman G. The pathogenesis of fat embolism. J Pathol. 1995; 176:3-9.
12. Driscoll DF, Etzler F, Barber T et al. Physicochemical stability assessments of parenteral, lipid emulsions: light obscuration versus laser diffraction. Int J Pharm. 2001; 219:21-37.
13. Reynolds JE, ed. Martindale: the extra pharmacopoeia. 29th ed. London: Pharmaceutical Press; 1989:1363.
14. Propofol 1% injectable emulsion package insert. Deerfield, IL: Baxter; revised 1999 Nov.
15. Propofol 1% injectable emulsion package insert. Deerfield, IL: Baxter; revised 2002 Jul.
16. Zaloga GP, Marik P. Sulfite-induced propofol oxidation. A cause for radical concern. Crit Care Med. 2003; 31:981-2.
17. Driscoll DF. The significance of particle/globule sizing measurements in the safe use of intravenous lipid emulsions. J Dispersion Sci Technol 2002; 23:679-87.
18. Diprivan 1% injectable emulsion package insert. Wilmington, DE: Zeneca Pharmaceuticals; revised 1998 Jan.
19. Driscoll DF, Bhargava HN, Li L et al. Physicochemical stability of total nutrient admixtures. Am J Health-Syst Pharm. 1995; 52:623-34.
20. Driscoll DF. Assessment of large-diameter outlier droplets/globules during coalescence of an intravenous lipid emulsion using light scattering (LS) and light extinction (LE) single-particle optical sensing (SPOS) techniques. Paper presented at Particles 2002. Orlando, FL; 2002 Apr 21.
21. Beaumont A, Marmarou A, Dunbar J. EEG burst suppression in the rat: propofol with EDTA versus sulfite-containing propofol for induction. Am J Anesthesiol. 2000; 27(6S):1-8.
22. El-Ebiary M, Torres A, Ramirez J et al. Lipid deposition during the long-term infusion of propofol. Crit Care Med. 1995; 23:1928-30.
23. Jasnosz KM, Pickeral JJ, Graner S. Fat deposits in the placenta following maternal total parenteral nutrition with intravenous lipid emulsion. Arch Pathol Lab Med. 1995; 119:555-7.
24. Driscoll DF, Bacon MN, Bistrian BR. The effects of filtration on lipid particle size distribution in total nutrient admixtures. JPEN J Parenter Enteral Nutr. 1996; 20: 296-301.
25. Hill SE, Heldman LS, Goo ED et al. Fatal microvascular emboli from precipitation of a total nutrient admixture solution. JPEN J Parenter Enteral Nutr. 1996; 20: 81-7.
26. Han J, Davis SS, Washington C. Physical properties and stability of two emulsion formulations of propofol. Int J Phartn. 2001; 215:207-20.
27. Baker MT, Dehring DJ, Gregerson MS. Sulfite supported lipid peroxidation in propofol emulsions. Anesthesiology. 2002; 97:1162-7.